Venus Remedies Limited (IN:VENUSREM)
:VENUSREM
Want to see IN:VENUSREM full AI Analyst Report?
Total Valuation
Venus Remedies Limited has a market cap or net worth of ₹24.08B. The enterprise value is ₹16.93B.
Market Cap₹24.08B
Enterprise Value₹16.93B
Share Statistics
Venus Remedies Limited has 13,366,988 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,366,988
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Venus Remedies Limited’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 13.44%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)13.44%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee6.48M
Profits Per Employee865.88K
Employee Count1,187
Asset Turnover0.90
Inventory Turnover3.88
Valuation Ratios
The current PE Ratio of Venus Remedies Limited is 23.4. Venus Remedies Limited’s PEG ratio is 0.08.
PE Ratio23.4
PS Ratio1.42
PB Ratio1.65
Price to Fair Value1.65
Price to FCF9.16
Price to Operating Cash Flow29.68
PEG Ratio0.08
Income Statement
In the last 12 months, Venus Remedies Limited had revenue of 7.70B and earned 1.03B in profits. Earnings per share was 76.89.
Revenue7.70B
Gross Profit2.68B
Operating Income1.22B
Pretax Income1.34B
Net Income1.03B
EBITDA1.47B
Earnings Per Share (EPS)76.89
Cash Flow
In the last 12 months, operating cash flow was 811.10M and capital expenditures -128.90M, giving a free cash flow of 682.20M billion.
Operating Cash Flow811.10M
Free Cash Flow682.20M
Free Cash Flow per Share51.04
Dividends & Yields
Venus Remedies Limited pays an annual dividend of ₹3, resulting in a dividend yield of ―
Dividend Per Share₹3
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.79
52-Week Price Change304.41%
50-Day Moving Average1.11K
200-Day Moving Average758.90
Relative Strength Index (RSI)83.63
Average Volume (3m)2.33K
Important Dates
Venus Remedies Limited upcoming earnings date is Aug 18, 2026, TBA (Confirmed).
Last Earnings DateMay 26, 2026
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
Venus Remedies Limited as a current ratio of 2.44, with Debt / Equity ratio of 1.87%
Current Ratio2.44
Quick Ratio1.64
Debt to Market Cap0.00
Net Debt to EBITDA-0.12
Interest Coverage Ratio3.04K
Taxes
In the past 12 months, Venus Remedies Limited has paid 313.70M in taxes.
Income Tax313.70M
Effective Tax Rate0.23
Enterprise Valuation
Venus Remedies Limited EV to EBITDA ratio is 7.32, with an EV/FCF ratio of 9.01.
EV to Sales1.40
EV to EBITDA7.32
EV to Free Cash Flow9.01
EV to Operating Cash Flow6.85
Balance Sheet
Venus Remedies Limited has ₹2.36B in cash and marketable securities with ₹143.80M in debt, giving a net cash position of ₹2.22B billion.
Cash & Marketable Securities₹2.36B
Total Debt₹143.80M
Net Cash₹2.22B
Net Cash Per Share₹165.94
Tangible Book Value Per Share₹496.55
Margins
Gross margin is 41.65%, with operating margin of 15.80%, and net profit margin of 13.35%.
Gross Margin41.65%
Operating Margin15.80%
Pretax Margin17.43%
Net Profit Margin13.35%
EBITDA Margin19.14%
EBIT Margin15.80%
Analyst Forecast
The average price target for Venus Remedies Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast17.97%
EPS Growth Forecast126.79%